Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Forsyth

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Molecular Oncology|July 3, 2013
Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumorsXueqing Lun, Yibing Ruan, Aarthi Jayanthan, et al.
Neuro-Oncology Practice|October 13, 2025
The CARING intervention for neuro-oncology family caregivers: Randomized controlled trial feasibility, eSNAP/caregiver navigation engagement, and acceptabilityHyojin Choi, Steven K Sutton, Deanna Witte, et al.
Cancer Research|November 5, 2002
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastomaEric C Burton, Kathleen R Lamborn, Burt G Feuerstein, et al.
Investigational New Drugs|October 31, 2003
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytomaKarl Bélanger, David MacDonald, Gregory Cairncross, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 15, 2022
Addressing a critical need for caregiver support in neuro-oncology: development of a caregiver navigation intervention using eSNAP social resource visualizationMaija Reblin, Kristen J Wells, Amy Otto, et al.
Cancer Chemotherapy and Pharmacology|June 6, 2009
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlationBrian Thiessen, Clinton Stewart, Ming Tsao, et al.
Journal of Neuro-Oncology|May 7, 2008
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysisNimish A Mohile, Peter Forsyth, Douglas Stewart, et al.
BMC Health Services Research|April 18, 2021
A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumorMaija Reblin, Dana Ketcher, Rachael McCormick, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomasKenneth B Fallon, Cheryl A Palmer, Kevin A Roth, et al.
Journal of Neurovirology|December 22, 2007
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cellsJohn W Barrett, Lindsay R Alston, Fuan Wang, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Molecular Oncology|July 3, 2013
Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumorsXueqing Lun, Yibing Ruan, Aarthi Jayanthan, et al.
Neuro-Oncology Practice|October 13, 2025
The CARING intervention for neuro-oncology family caregivers: Randomized controlled trial feasibility, eSNAP/caregiver navigation engagement, and acceptabilityHyojin Choi, Steven K Sutton, Deanna Witte, et al.
Cancer Research|November 5, 2002
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastomaEric C Burton, Kathleen R Lamborn, Burt G Feuerstein, et al.
Investigational New Drugs|October 31, 2003
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytomaKarl Bélanger, David MacDonald, Gregory Cairncross, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 15, 2022
Addressing a critical need for caregiver support in neuro-oncology: development of a caregiver navigation intervention using eSNAP social resource visualizationMaija Reblin, Kristen J Wells, Amy Otto, et al.
Cancer Chemotherapy and Pharmacology|June 6, 2009
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlationBrian Thiessen, Clinton Stewart, Ming Tsao, et al.
Journal of Neuro-Oncology|May 7, 2008
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysisNimish A Mohile, Peter Forsyth, Douglas Stewart, et al.
BMC Health Services Research|April 18, 2021
A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumorMaija Reblin, Dana Ketcher, Rachael McCormick, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomasKenneth B Fallon, Cheryl A Palmer, Kevin A Roth, et al.
Journal of Neurovirology|December 22, 2007
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cellsJohn W Barrett, Lindsay R Alston, Fuan Wang, et al.
Pageof 8